Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry

K.I.E. Ibragimova, S.M.E. Geurts, S. Croes, F. Erdkamp, J.B. Heijns, J. Tol, B.E.P.J. Vriens, K.N.A. Aaldering, M.W. Dercksen, M.J.A.E. Pepels, N.A.J.B. Peters, L. van de Winkel, D.J.P. Tilli, I.J.H. Vriens, M. de Boer, V.C.G. Tjan-Heijnen*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Fingerprint

Dive into the research topics of 'Survival before and after the introduction of pertuzumab and T-DM1 in HER2-positive advanced breast cancer, a study of the SONABRE Registry'. Together they form a unique fingerprint.

Keyphrases

INIS

Pharmacology, Toxicology and Pharmaceutical Science

Agricultural and Biological Sciences

Neuroscience